EQS-News: Heidelberg Pharma AG / Key word: Annual Report
Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business
24.03.2023 / 07:11. | March 24, 2023
/PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it plans to.
RedHill Biopharma Announces Plan to Implement ADS Ratio Change streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ BioVentrix®, Inc., a privately held medical device company developing less invasive therapies to directly treat the dilated left ventricle.